John Brown joins BioCity Nottingham board
This article was originally published in Scrip
Executive Summary
Dr John Brown has been appointed a non-executive director of the board of BioCity Nottingham, a UK-based bioscience incubator, just two weeks after the launch of BioCity Scotland. Dr Brown is currently chair of CXR Biosciences and a non-executive director of Vectura Group. He also chairs the Roslin Foundation, co-chairs the Life Sciences Industry Advisory Board for the Scottish government and is a non-executive director of the Technology Strategy Board. He was appointed CBE for services to science in June 2011.
You may also be interested in...
Almirall launches Constella in six European markets
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira raises $35m in series B
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis ups public offering to $240m
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.